Condition

Percutaneous Coronary Intervention

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 21 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials21
Recruiting4
Common interventions25
Lead sponsors shown15
Advertisement

Clinical trials

21 shown
Comparative Effectiveness of Dual Antihypertensive Regimens in Patients After Percutaneous Coronary InterventionNCT07683585 · 2026-04-01
RECRUITING
Cardio-Renal RegistryNCT06521801 · 2024-08-01
RECRUITING
Temporary MCS With the iVAC 2L Transaortic Device in High-risk PCINCT07149714 · 2023-02-17
RECRUITING
Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) TrialNCT04982419 · 2021-11-01
RECRUITING
Overviewing Real-World Outcomes to Boost Interventional Management of CAlcified Coronary Lesions: the OROBICA Registry.NCT07566403 · 2026-06-30
NOT_YET_RECRUITING
Polymer-free Sirolimus Eluting Stent: Real-world Investigation of Safety and OutcomesNCT07563231 · 2026-06-01
NOT_YET_RECRUITING
Improving Cardiac Rehabilitation Exercise Using Target Heart Rate TrialNCT05925634 · 2023-08-10
ACTIVE_NOT_RECRUITING
REgiStry-based Cardiovascular qUality improvEment ResearchNCT06137885 · 2023-04-24
UNKNOWN
Native Coronary Artery Instead of SAphenous Vein Graft Intervention for Treatment of Significant Saphenous Vein Graft LesionsNCT05187351 · 2021-11-21
ACTIVE_NOT_RECRUITING
Improving Cardiac Rehabilitation Outcomes Through Mobile Case Management (iCARE)NCT04938661 · 2021-07-08
COMPLETED
Correlation Between Targeted HbA1c Values and Prevention of Recurrent Cardiovascular Events in Type 2 Diabetes After PCINCT05134129 · 2021-04-25
UNKNOWN
Enhancing Cardiac Rehabilitation Through Behavioral NudgesNCT03834155 · 2019-05-17
COMPLETED
Effects of Evolocumab on Platelet Reactivity in Patients With Diabetes MellitusNCT03258281 · 2018-05-01
TERMINATED
Text Message Intervention to Improve Cardiac Rehab ParticipationNCT03346278 · 2017-11-07
TERMINATED
Safety and Efficacy of Empagliflozin for Patients With Diabetes Mellitus and Planned Percutaneous Coronary InterventionsNCT04497792 · 2016-11-01
COMPLETED
Evaluation of Novel Risk Factors and Clinical Outcomes of Acute Myocardial InfarctionNCT02641184 · 2015-12-01
UNKNOWN
Cardiac Rehabilitation Peer MentorshipNCT02204449 · 2014-07-01
COMPLETED
The Titan Versus Everolimus Intracoronary Stent (Xience V) in Diabetic PatientsNCT01510509 · 2009-01-01
UNKNOWN
Comparison of Biodegradable Polymer vs Durable-polymer in Diabetic PatientsNCT02854423 · 2007-01-01
COMPLETED
Intravenous Insulin in Patients With Diabetes After Percutaneous Coronary Intervention (PCI)NCT00967642 · 2006-08-01
TERMINATED
Prevention of Instent Renarrowing With Aggressive Glucose Lowering With Pioglitazone in Diabetic PatientsNCT00819325 · 2002-08-01
COMPLETED

Common interventions

Leading sponsors

Trial status mix

COMPLETED6
RECRUITING4
UNKNOWN4
TERMINATED3
ACTIVE_NOT_RECRUITING2
NOT_YET_RECRUITING2

Phase mix

NA8
PHASE44
PHASE21
PHASE31
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.